Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Murali Krishna Moka

ResearcherPublications, citations & collaboration network

Murali Krishna Moka is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 9 works, 19 citations, an h-index of 3 and an i10-index of 0.

9
Works
19
Citations
3
h-index
0
i10-index

How has Murali Krishna Moka's publication output changed over time?

ScholarIQpublication output · 2024–2025

Output grew100% over the shown period — from 3 works in 2024 to 6 in 2025.

3
6
20242025

What are the most-cited papers on Murali Krishna Moka?

ScholarIQmost cited works
Trends in drug repurposing: Advancing cardiovascular disease management in geriatric populations
Murali Krishna Moka, Melvin George, Deepalaxmi Rathakrishnan, V Jagadeeshwaran, D K Sriram
S2898475623. 20254 Citations
Overcoming barriers to unlock the therapeutic potential of saroglitazar for the management of metabolic dysfunction-associated steatotic liver disease
Murali Krishna Moka, Deepalaxmi Rathakrishnan, D K Sriram, Melvin George
Clinical Nutrition. 20252 Citations
Advancing therapeutic approaches and shaping future perspectives in the management of autosomal dominant polycystic kidney disease (ADPKD): Insights from clinical trials
Murali Krishna Moka, Deepalaxmi Rathakrishnan, D.K. Sriram, Melvin George
European Journal of Pharmacology. 20252 Citations

Related on ScholarIQ

Hindu Mission Hospital
Institution
“Emerging clinical approaches in diabetic cardiomyopathy: insights from clinical trials and future directions”
Paper
Trends in drug repurposing: Advancing cardiovascular disease management in geriatric populations
Paper
Recent Advances in Individualized Clinical Strategies for Polycystic Ovary Syndrome: Evidence From Clinical Trials and Emerging Pharmacotherapies
Paper
Overcoming barriers to unlock the therapeutic potential of saroglitazar for the management of metabolic dysfunction-associated steatotic liver disease
Paper
Advancing therapeutic approaches and shaping future perspectives in the management of autosomal dominant polycystic kidney disease (ADPKD): Insights from clinical trials
Paper
470M+ articles · free account